This site is intended for Healthcare Professionals only.

Tag: Advance lung cancer


‘Durvalumab’ can improve life span of lung cancer patients

The drug, ‘durvalumab’, can double the overall time someone can survive with an aggressive form of lung cancer from two-and-a-half to five years. It has...

NICE recommends Tepotinib for advanced lung cancer

'Tepotinib’ has been recommended by the National Institute for Health and Care Excellence (NICE) to patients with a specific gene mutation of advanced non-small-cell...